Cytotoxicity Study Using the ISO Elution Method

The cytotoxicity ISO elution method assesses the potential toxicity of medical devices by evaluating the effects of eluates (extracts) from the device materials on cultured cells. This test determines whether any harmful substances leach from the device and cause adverse effects on cell viability, proliferation, or morphology. Ensuring that eluates are non-toxic is crucial for patient safety and biocompatibility.

Why This Assessment is Performed

Cytotoxicity elution method testing is performed to ensure that medical devices do not release harmful substances that could negatively impact living cells. This testing helps identify any toxic leachables that might be present in the device materials, ensuring that the device is safe for use in medical applications.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting This Test

1. Sample Preparation: Prepare samples of the medical device material for extraction.
2. Extraction: Extract the device material using a suitable solvent to obtain eluates.
3. Cell Culture: Culture appropriate cell lines, such as fibroblasts or epithelial cells, in a controlled environment.
4. Eluate Exposure: Expose the cultured cells to the eluates for a specified period, typically 48 hours.
5. Evaluation: Assess cell viability, proliferation, and morphology using microscopic examination.
6. Interpretation: Assign a grade of cytotoxicity based on the severity of the response (Grades 0-4) as stated in ISO 10993-5.

Standards, Guidance, and Regulations

When conducting cytotoxicity ISO elution method testing for medical devices, it is essential to follow specific standards and guidelines:

• ISO 10993-5: This international standard provides guidelines for in vitro cytotoxicity testing of medical devices, including the elution method.
• FDA Guidance: The U.S. Food and Drug Administration (FDA) provides specific guidance on conducting cytotoxicity testing for medical devices within the FDA Guidance to Industry – Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”.